Surgery Partners, Inc. (SGRY) Social Stream
SURGERY PARTNERS INC (SGRY) Price Targets From Analysts
Use the tables below to see what analysts covering SURGERY PARTNERS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 7 | $78 | $50 | $61.125 | $26.55 | 130.23% |
| 2021-11-09 | 7 | $78.001 | $50 | $61.125 | $26.55 | 130.23% |
| 2021-11-29 | 7 | $78.001 | $50 | $61.125 | $26.55 | 130.23% |
| 2021-11-30 | 8 | $78.001 | $50 | $62.444 | $26.55 | 135.19% |
| 2021-12-03 | 8 | $78.001 | $50 | $63.444 | $26.55 | 138.96% |
| 2021-12-08 | 8 | $78 | $50 | $62.222 | $26.55 | 134.36% |
| 2022-01-07 | 8 | $75 | $50 | $61.333 | $26.55 | 131.01% |
| 2022-01-10 | 9 | $75 | $50 | $62.111 | $26.55 | 133.94% |
| 2022-01-25 | 9 | $75 | $50 | $62.333 | $26.55 | 134.78% |
| 2022-03-01 | 9 | $75 | $50 | $63.111 | $26.55 | 137.71% |
| 2022-05-03 | 9 | $75 | $55 | $63.888 | $26.55 | 140.63% |
| 2022-05-04 | 9 | $75 | $55 | $66 | $26.55 | 148.59% |
| 2022-05-10 | 9 | $75 | $57 | $66.222 | $26.55 | 149.42% |
| 2022-06-14 | 9 | $75 | $55 | $64.555 | $26.55 | 143.15% |
| 2022-06-15 | 9 | $75 | $36 | $62.444 | $26.55 | 135.19% |
| 2022-08-02 | 9 | $75 | $42 | $63.111 | $26.55 | 137.71% |
| 2022-08-03 | 9 | $75 | $42 | $61.333 | $26.55 | 131.01% |
| 2022-08-05 | 10 | $75 | $39 | $59.3 | $26.55 | 123.35% |
| 2022-08-13 | 9 | $75 | $39 | $59.3 | $26.55 | 123.35% |
| 2022-09-21 | 9 | $75 | $34 | $58.5 | $26.55 | 120.34% |
| 2022-11-09 | 7 | $75 | $30 | $55.5 | $26.55 | 109.04% |
| 2022-11-10 | 10 | $73 | $30 | $53.1 | $26.55 | 100% |
| 2022-11-15 | 10 | $73 | $30 | $52.7 | $26.55 | 98.49% |
| 2022-11-22 | 10 | $73 | $30 | $50.4 | $26.55 | 89.83% |
| 2022-11-23 | 10 | $73 | $30 | $49.4 | $26.55 | 86.06% |
The Trend in the Analyst Price Target
SGRY's average price target has moved down $11.73 over the prior 13 months.
SGRY reports an average of 63.52% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 8 | 78.001 | 50 | 62.444 | 44.36 | 40.77% |
| 2022-03-02 | 9 | 75.000 | 55 | 63.888 | 56.42 | 13.24% |
| 2022-08-05 | 10 | 75.000 | 39 | 59.300 | 36.90 | 60.7% |
| 2022-11-09 | 7 | 75.000 | 30 | 55.500 | 22.30 | 148.88% |
| 2022-11-15 | 10 | 73.000 | 30 | 52.700 | 29.00 | 81.72% |
SGRY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.7 | 6 | 1 | 3 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 48 weeks, SGRY's average broker recommendation rating worsened by 0.2.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, SURGERY PARTNERS INC's upside potential (average analyst target price relative to current price) is higher than 2214.27% of them.
- SGRY has a higher average analyst price target than 2036.75% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, SURGERY PARTNERS INC's number of analysts covering the stock is higher than 1986.53% of them.
- In the context of stocks in the mid market cap category, SURGERY PARTNERS INC's variance in analysts' estimates is lower than -1711.92% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Healthcare industry with the ratings most similar to SURGERY PARTNERS INC are SEM, MD, and ENSG.
View All Top Stocks by Price Target
Is SGRY a Buy, Hold or Sell? See the POWR Ratings now!